1. The MTOPS Study: New Findings, New Insights, and Clinical Implications for the Management of BPH 
Michael Marberger 
European Urology Supplements 
Volume 5, Issue 9, Pages (June 2006)
DOI: /j.eursup
Copyright © 2006 European Association of Urology Terms and Conditions

2. Fig. 1
Cumulative incidence of progression of benign prostatic hyperplasia in the Medical Therapy of Prostate Symptoms (MTOPS) Study. Reproduced with permission from McConnell J et al. N Engl J Med 2003;349:2387–98.
European Urology Supplements 2006 5, DOI: ( /j.eursup )
Copyright © 2006 European Association of Urology Terms and Conditions

3. Fig. 2
Cumulative incidence of acute urinary retention in men receiving finasteride, doxazosin, a combination of both, or placebo in the Medical Therapy of Prostate Symptoms (MTOPS) Study. Reproduced with permission from McConnell J et al. N Engl J Med 2003;349:2387–98.
European Urology Supplements 2006 5, DOI: ( /j.eursup )
Copyright © 2006 European Association of Urology Terms and Conditions

4. Fig. 3
Change from baseline in prostate volume at 4 yr in the Medical Therapy of Prostate Symptoms (MTOPS) Study [7].
European Urology Supplements 2006 5, DOI: ( /j.eursup )
Copyright © 2006 European Association of Urology Terms and Conditions